The augmented phosphorylation/activation of PDGFR and the proteins in the pathways leads to reduced apoptosis, increased cell cycle progression and cell proliferation, and increased survival of the anticancer drug-treated cancer cells. This evidence concerns the gene PDGFRB and cancer.